Asthma and
Pulmonary Fibrosis

The Asthma and Pulmonary Fibrosis Research Team focuses on thoracic translational medicine, dedicated to integrating basic research and clinical practice. They delve into the pathogenesis, disease progression, and treatment responses of asthma and pulmonary fibrosis, accumulating landmark research findings in related fields. The team's core research goals are to improve clinical treatment efficacy and enhance patients' health and quality of life. They actively employ advanced single-cell analysis techniques to systematically analyze disease-related cellular heterogeneity and key molecular regulatory networks, thereby identifying potentially clinically viable therapeutic targets, promoting the development of precise and highly effective targeted drugs, and further strengthening clinical treatment strategies. Through the deep integration of cutting-edge technology and interdisciplinary research, we are able to gain a more comprehensive understanding of the disease progression mechanisms of asthma and pulmonary fibrosis, accelerating the development and clinical application of innovative treatment strategies. Every research and technological breakthrough reflects our team's long-term commitment to precision medicine and translational applications, striving to transform innovative research results into treatment plans with substantial clinical value.